What is the best treatment approach for a patient with dizziness, prediabetes, vitamin D deficiency, asthma, and elevated liver enzymes, and which additional labs should be ordered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Approach for a Patient with Dizziness, Prediabetes, Vitamin D Deficiency, Asthma, and Elevated Liver Enzymes

The most appropriate treatment approach for this patient should prioritize vitamin D supplementation with 2,000 IU daily to correct the deficiency, alongside investigation of elevated liver enzymes through additional testing including hepatitis serologies, iron studies, and autoimmune markers. 1, 2

Vitamin D Deficiency Management

  • The patient's vitamin D level of 26.6 ng/mL indicates insufficiency (defined as 20-30 ng/mL), which requires treatment to reach optimal levels of 30-40 ng/mL 2, 3
  • For vitamin D insufficiency, supplementation with 2,000 IU of vitamin D3 (cholecalciferol) daily is recommended to increase levels by approximately 10-15 ng/mL over 3 months 2, 4
  • Once target levels of >30 ng/mL are achieved, a maintenance dose of 800-1,000 IU daily should be continued to maintain optimal levels 3, 5
  • Vitamin D supplementation may help improve symptoms of dizziness related to the deficiency and has been associated with improved clinical outcomes in patients with liver disease 6

Elevated Liver Enzymes Evaluation

  • The elevated ALT (68 IU/L) requires further investigation as it suggests possible liver injury or disease 1, 7
  • Initial assessment should include repeating liver function tests in 2-5 days to confirm persistence of elevation 7
  • The pattern of liver enzyme elevation (hepatocellular vs. cholestatic) should be determined by checking additional liver tests including AST, alkaline phosphatase, GGT, and bilirubin 1, 7
  • For mild elevations (<3× upper limit of normal), monitoring can continue while investigating potential causes 7

Additional Laboratory Tests Recommended

  • Complete hepatitis panel (HAV, HBV, HCV) to rule out viral hepatitis 1
  • Autoimmune markers including ANA, anti-smooth muscle antibody, and immunoglobulin levels to evaluate for autoimmune hepatitis 6
  • Iron studies (ferritin, iron, TIBC) as elevated ferritin has been associated with autoimmune hepatitis treatment response 6
  • Alpha-1 antitrypsin level and phenotype given the history of asthma and liver enzyme elevation 6
  • Ceruloplasmin to rule out Wilson's disease as a cause of liver enzyme elevation 1
  • Fasting glucose and insulin levels to better characterize the prediabetic state and its potential contribution to fatty liver disease 7
  • Lipid panel to assess cardiovascular risk and potential contribution to fatty liver 1

Prediabetes Management

  • For the patient with prediabetes (HbA1c 6.0%), lifestyle modifications including diet and exercise should be implemented 7
  • Dietary changes should emphasize reduced intake of saturated fats and increased consumption of fruits, vegetables, and whole grains 6
  • Regular physical activity should be encouraged to improve insulin sensitivity and help manage blood sugar levels 6

Asthma Management

  • Continue current asthma medications (Advair Diskus, Albuterol) with regular monitoring of symptoms 6
  • Ensure proper inhaler technique and adherence to maintenance therapy 6
  • Monitor for any exacerbations that could contribute to dizziness through hypoxia or medication side effects 6

Monitoring and Follow-up

  • Recheck vitamin D levels after 3 months of supplementation to ensure target levels >30 ng/mL are achieved 2, 3
  • Monitor liver enzymes every 2-4 weeks until normalized or a diagnosis is established 1, 7
  • If liver enzymes remain elevated despite initial workup, consider referral to hepatology for further evaluation including possible liver biopsy 6
  • Regular follow-up of HbA1c every 3-6 months to monitor prediabetes status 7

Potential Pitfalls and Considerations

  • Avoid high single doses of vitamin D (>300,000 IU) as these have been associated with adverse effects 4
  • Be aware that certain medications can cause elevated liver enzymes, including some commonly used drugs; review the patient's complete medication list 1, 8
  • Consider rare causes of elevated liver enzymes such as adrenal insufficiency if common etiologies are ruled out 9
  • Recognize that vitamin D deficiency has been associated with histological severity, poor treatment response, and progression to cirrhosis in patients with autoimmune hepatitis 6
  • Ensure that sodium intake is not excessively restricted in patients with liver disease, as this can lead to hyponatremia and worsen symptoms 6

By addressing the vitamin D deficiency, investigating the elevated liver enzymes, and managing the prediabetes and asthma, this comprehensive approach should help improve the patient's symptoms of dizziness while preventing progression of any underlying liver disease.

References

Guideline

Diagnostic Approach and Treatment for Elevated Bilirubin and Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Correcting vitamin D deficiency using over-the-counter supplements.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012

Research

Recognition and management of vitamin D deficiency.

American family physician, 2009

Research

Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Mildly Elevated Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefoperazone-Induced Transaminitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.